Fortive Corporation with ticker code (FTV) now have 15 analysts in total covering the stock. The consensus rating is pointing to ‘Buy’. The target price High/Low ranges between 87 and 63 suggesting an average Analsyt target price of $73.87. Given that the stocks previous close was at $66.87 this would indicate that there is a potential upside of 10.5%. Also worth taking note is the 50 day moving average now sits at $66.54 and the 200 day MA is $64.71. The company has a market capitalization of $23,071m. You can visit the company’s website by visiting: https://www.fortive.com
The potential market cap would be $25,486m based on the market consensus.
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Intelligent Operating Solutions segment provides advanced instrumentation, software and services, which includes electrical test and measurement, facility and asset lifecycle software applications, and worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. Additionally, it markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. Its Precision Technologies segment provides electrical test & measurement, sensing and material technologies under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries. Advanced Healthcare Solutions segment offers critical workflow solutions including instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. The company was incorporated in 2015 and is headquartered in Everett, Washington.
The company has a dividend yield of 0.42% with the ex dividend date set at 25-5-2023 (DMY).
Other points of data to note are a P/E ratio of 31.1, revenue per share of 16.35 and a 3.97% return on assets.
